American College of Rheumatology guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 4
JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2022 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …
American College of Rheumatology Guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5
JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2023 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …
COVID-19 outcomes and vaccination in patients with spondyloarthritis
A Deodhar, S Bhana, K Winthrop… - Rheumatology and therapy, 2022 - Springer
The rapid transmission of the highly infectious severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), led to …
coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), led to …
Vaccinations in Selected Immune-Related Diseases Treated with Biological Drugs and JAK Inhibitors—Literature Review and Statement of Experts from Polish …
J Narbutt, Z Żuber, A Lesiak, N Bień, JC Szepietowski - Vaccines, 2024 - mdpi.com
The growing use of biological drugs in immune-mediated chronic diseases has undoubtedly
revolutionized their treatment. Yet, the topic of vaccinations in this group of patients still …
revolutionized their treatment. Yet, the topic of vaccinations in this group of patients still …
Sleep Disturbance and SARS–CoV‐2 Vaccinations in Patients With Chronic Inflammatory Disease
N Pawar, KE Taylor, M Yang, P Deepak… - Arthritis Care & …, 2023 - Wiley Online Library
Objective Immunocompromised patients with chronic inflammatory disease (CID) may have
experienced additional psychosocial burden during the COVID‐19 pandemic due to their …
experienced additional psychosocial burden during the COVID‐19 pandemic due to their …
Sleep disturbance improves with SARS‐COV2 vaccinations in patients with Chronic Inflammatory Disease
N Pawar, KE Taylor, M Yang, P Deepak… - Arthritis Care & …, 2022 - ncbi.nlm.nih.gov
Objective Immunocompromised patients with chronic inflammatory diseases (CID) may have
experienced additional psychosocial burden during the COVID‐19 pandemic due to an …
experienced additional psychosocial burden during the COVID‐19 pandemic due to an …
[HTML][HTML] An official publication of the ACR and the ARP serving rheumatologists and rheumatolgy professionals
K Holliman - 2020 - the-rheumatologist.org
Three new consensus documents from the ACR address critical issues in patient care:
management of lupus nephritis (LN); using disease-modifying antirheumatic drugs …
management of lupus nephritis (LN); using disease-modifying antirheumatic drugs …